Support for NIH Clinical Trial Diversity Act (H.R. 7845)

Florence Fee (No Health without Mental Health), along with many other leaders of professional organizations associated with health care such as American Academy of Family Physicians, American Cancer Society Cancer Action Network, American College of Physicians, American Medical Association
American Psychiatric Association, American Psychological Association, have written a thoughtful, supportive letter commending key leaders in the US House of Representatives for bipartisan leadership in advancing the Food and Drug Amendments of 2022, and specifically the inclusion of Food and Drug Administration (FDA) policies to improve clinical trial diversity.

Their goal is to ask the members of the Energy and Commerce Committee to take steps to complement these policies by enacting policies to improve clinical trial diversity across a wide range of clinical research funded by the National Institutes of Health (NIH).  For more information, please check out https://www.congress.gov/bill/117th-congress/house-bill/7845/actions?r=1&s=1 or contact Florence at florencefee@nhmh.org.